Skip to main content

Preparing Your Practice for Presbyopia

Tracking # 20-956882

Price not reported

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Lecture
Dates Contact provider

Course overview

This course will be an introduction to understanding the opportunity and clinical protocols in anticipation of therapeutics for presbyopia. You will learn about the theories of presbyopia, risk factors, and various corrective options ranging from spectacles to surgical. You will observe top experts in the field of presbyopia and see how they educate patients. Finally you will be introduced to the various treatment approaches and which patients are likely to do well with these medications.

Subject areas

This course counts toward the state boards and subject areas below.

Texas Optometry Board

Optometrist

1h General

Disclosure statements

I have read and will comply with the COPE requirements for course qualification. I further

agree to notify COPE in writing should any information provided, including financial/proprietary

information, change at any time during the three year qualification period of this course.

I agree that I will keep my presentation free from commercial interest or bias. I will maintain

independent control over the content of my presentation, so that it is balanced, objective,

presented with scientific rigor and not be for the purpose of promoting products, equipment,

etc. (Therefore, my presentation should not be perceived by attendees as a commercial.) I

further agree that I will not change the basic content of my presentation following approval.

I agree to disclose to the audience the existence of any significant financial/professional

relationships with the manufacturer(s) of any commercial product(s) and/or the provider(s) of

any commercial service(s) discussed in the educational presentation. (Said relationships can

include such things as grant/research support, employment, consulting and/or speakers bureau

arrangements, major stock ownership, etc.) I will disclose any of these relationships, whether

or not there is direct commercial support for the CE activity. This disclosure is made to provide

the audience the information on which they can make judgments as to a presenter’s objectivity.

I agree to disclose the attendees; a) when products or procedures being discussed are off label,

unlabeled, experimental, and/or investigational (not FDA approved); b) any limitations on the

information that is presented, such as data that are preliminary or that represent ongoing

research, interim analyses, and/or unsupported opinion.

I agree I have an ethical responsibility to make appropriate decisions related to my

presentation, and all issues involving financial remuneration.